Skip to main content
Deborah Goldstein, MD, Infectious Disease, Washington, DC, George Washington University Hospital

DeborahAnnaGoldsteinMD

Infectious Disease • Washington, DC

HIV/AIDS Medicine

Physician

Join to view full profile

Dr. Goldstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Goldstein's full profile

Already have an account?

Summary

  • I am a board certified Infectious Disease specialist and spent the past decade practicing HIV care, primary care, and gender-affirming clinical care at Whitman-Walker Health, a Federally Qualified Health Center in Washington DC. For the past five years, as the Director of Clinical Research at WWH, I was the Primary Investigator for 25 phase 1, 2 and 3 HIV and Hepatitis C treatment and prevention studies with over 200 participants, including phase 1 HIV cure study and phase 3 HIV prevention vaccine study.

Education & Training

  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalFellowship, Infectious Disease, 2007 - 2009
  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2003 - 2006
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003
  • Amherst College
    Amherst CollegeBA, 1994 - 1998

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2021 - 2024
  • DC State Medical License
    DC State Medical License 2005 - 2024
  • VA State Medical License
    VA State Medical License 2005 - 2022

Awards, Honors, & Recognition

  • Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016

Publications & Presentations

PubMed

Abstracts/Posters

  • Trans Females Receiving Gender-Affirming Surgical Referrals are More Likely to Have Durable Virologic Suppression at Whitman-Walker Health, 2008-2017.
    Deborah Goldstein, Eleanor Sarkodie, David Hardy, IDWeek, Washington, DC, 2019
  • Safety and Efficacy of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naïve HIV-1 Infected Adults with Transmitted Non-Nucleoside Rever...
    Alexander Wong, Deborah Goldstein, Josep Mallolas, Edwin DeJesus, Margaret Johnson, Jean-Michel Molina, Anton Pozniak, Anthony Rodgers, Valerie Teal, Deborah Hepler, S..., HIV Glasgow, 2018
  • Week 96 efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in older, HIV-infected treatment-naive adults.
    Douglas Ward, Melanie Thompson, Deborah Goldstein, Cynthia Brinson, Gordon Crofoot, Clifford Kinder, Hui Wang, Julie Ryu, Ian McNicholl, Richard Haubrich, MD, Amy Wein..., American College of Clinical Pharmacology, 2017
  • Join now to see all

Press Mentions

  • Gender-Affirming Hormone Therapy May Increase Risk of High Blood Pressure
    Gender-Affirming Hormone Therapy May Increase Risk of High Blood PressureApril 19th, 2021
  • Utilization of Direct Oral Anticoagulants in People Living with Human Immunodeficiency Virus: Observational Data from the District of Columbia Cohort
    Utilization of Direct Oral Anticoagulants in People Living with Human Immunodeficiency Virus: Observational Data from the District of Columbia CohortMarch 17th, 2020
  • Whitman-Walker seeks volunteers for HIV vaccine study
    Whitman-Walker seeks volunteers for HIV vaccine study November 5th, 2020

Committees

  • PMPC Member, Pharmacy and Medical Policy Committee, BlueCross BlueShield Federal Employees Program 2013 - Present

Hospital Affiliations

Dr. Deborah Goldstein, Dr. Deborah Goldstein, MD, Dr. D Goldstein, Dr. Deborah Anna Goldstein